Baxdrostat is a highly selective, second-generation, nonimidazole aldosterone synthase inhibitor; 100 times less baxdrostat ...

Even in people without high blood pressure, subclinical primary aldosteronism is linked to a significantly higher risk for ...

In a new clinical practice guideline, the Endocrine Society advises universal screening of those with hypertension by ...

A phase 2 trial evaluated the efficacy and safety of lorundrostat in hypertensive patients with chronic kidney disease (CKD) and albuminuria.

Screening should include measuring aldosterone and renin and determining the aldosterone-to-renin ratio.

An international team of researchers led by Professor Morris Brown FRS at Queen Mary University of London found that ...

Aldosterone helps balance blood levels of sodium and potassium, researchers said. Levels that are too high can cause people ...

AstraZeneca announced that baxdrostat, a selective aldosterone synthase inhibitor, met its primary and all secondary ...

Renal replacement therapy prolongs life in patients with Stage 5 chronic kidney disease. Сardiovascular diseases are the main ...

The phase 3 BaxHTN trial has been evaluating two doses of the drug in patients with uncontrolled hypertension being treated ...